Literature DB >> 7595571

Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain.

C Thiffault1, N Aumont, R Quirion, J Poirier.   

Abstract

Excessive free radical formation or antioxidant enzyme deficiency can result in oxidative stress, a mechanism proposed in the toxicity of MPTP and in the etiology of Parkinson's disease (PD). However, it is unclear if altered antioxidant enzyme activity is sufficient to increase lipid peroxidation in PD. We therefore investigated if MPTP can alter the activity of the antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX) and the level of lipid peroxidation. L-Deprenyl, prior to MPTP administration, is used to inhibit MPP+ formation and its subsequent effect on antioxidant enzymes. MPTP induced a threefold increase in SOD activity in the striatum of C57BL/6 mice. No parallel increase in GSH-PX or CAT activities was observed, while striatal lipid peroxidation decreased. At the level of the substantia nigra (SN), even though increases in CAT activity and reduction in SOD and GSH-PX activities were detected, lipid peroxidation was not altered. Interestingly, L-deprenyl induced similar changes in antioxidant enzymes and lipid peroxidation levels, as did MPTP. Taken together, these results suggest that an alteration in SOD activity, without compensatory increases in CAT or GSH-PX activities, is not sufficient to induce lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595571     DOI: 10.1046/j.1471-4159.1995.65062725.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.

Authors:  K Grasing; R Azevedo; S Karuppan; S Ghosh
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

3.  MPTP decreases MT-I mRNA in mouse striatum.

Authors:  P Rojas; J Rojas-Castañeda; R M Vigueras; S S Habeebu; C Rojas; C Ríos; M Ebadi
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 4.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

5.  Effects of selegiline on antioxidant systems in the nigrostriatum in rat.

Authors:  K Takahata; S Shimazu; H Katsuki; F Yoneda; A Akaike
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

6.  Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.

Authors:  Muralikrishnan Dhanasekaran; Christian B Albano; Lori Pellet; Senthilkumar S Karuppagounder; Subramaniam Uthayathas; Vishnu Suppiramaniam; Holly Brown-Borg; Manuchair Ebadi
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

7.  Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets.

Authors:  Kiyoshi Ando; Jun Maeda; Motoki Inaji; Takashi Okauchi; Shigeru Obayashi; Makoto Higuchi; Tetsuya Suhara; Yoshikuni Tanioka
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

Review 8.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

9.  Dopamine agonist 3-PPP fails to protect against MPTP-induced toxicity.

Authors:  Dhanasekaran Muralikrishnan; Manuchair Ebadi; Holly M Brown-Borg
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

10.  Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.

Authors:  Harikesh Kalonia; Puneet Kumar; Anil Kumar; Bimla Nehru
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.